SIGA Technologies, Inc. (NASDAQ:mbol/siga/real-time SIGA), a pharmaceutical company, was set up in 1995 and is now based in New York City. The company markets on pharmaceutical solutions for smallpox, Ebola, dengue, Lassa fever, and other lethal disease-causing pathogens.